This gene shapes how your body handles cholesterol — both in your bloodstream and your brain. Certain versions raise your risk of memory decline and heart disease later in life, while others are protective. Knowing yours changes what you eat, how you exercise, and what to watch for.
See your APOE variants — freeAPOE carries cholesterol and other lipids between cells and tissues, including across the blood-brain barrier. Different versions of the gene (ε2, ε3, ε4) clear cholesterol with different efficiency, bind LDL receptors with different affinity, and interact differently with neurons in the brain — particularly in clearing beta-amyloid, the protein that accumulates in Alzheimer's disease.
ε4 carriers tend to have higher LDL cholesterol and a substantially elevated risk of late-onset Alzheimer's disease (one ε4 ≈ 2-3x; two ε4 ≈ 8-12x lifetime risk vs. ε3/ε3). ε2 carriers are generally protected against Alzheimer's but may have higher triglycerides and rare type-III hyperlipidemia. Knowing your genotype changes how you should interpret blood lipids, design diet, and prioritize aerobic exercise — which has outsized cognitive benefit in ε4 carriers.
| rsID | Alias | Risk allele | Effect | Frequency |
|---|---|---|---|---|
rs429358 | — | — | Defines ε4 vs ε3/ε2 (C = ε4 allele) | C allele ≈14% globally |
rs7412 | — | — | Defines ε2 vs ε3/ε4 (T = ε2 allele) | T allele ≈8% globally |
| Genotype | Prevalence | What it means | What to do |
|---|---|---|---|
| ε3/ε3 | ~60% of Europeans | Average cholesterol handling and Alzheimer risk. | Standard heart-healthy lifestyle; no genotype-specific intervention. |
| ε3/ε4 | ~20-25% | Elevated LDL; ~2-3x lifetime Alzheimer risk vs ε3/ε3. | Mediterranean / MIND diet, 150+ min/wk aerobic exercise, monitor ApoB and Lp(a). |
| ε4/ε4 | ~2-3% | Highest LDL; ~8-12x lifetime Alzheimer risk. | Aggressive lifestyle — Mediterranean diet, daily aerobic exercise, sleep optimization, alcohol minimization, hearing protection. Discuss statin/PCSK9 with cardiologist. |
| ε2/ε3 or ε2/ε2 | ~13% | Lower Alzheimer risk; potentially elevated triglycerides; rare type-III hyperlipidemia in ε2/ε2. | Watch triglycerides; limit refined carbs and alcohol; standard lipid screening. |
| Condition | Relationship | Detail |
|---|---|---|
| Late-onset Alzheimer's disease | Increased risk (ε4) / Protective (ε2) | ε4 is the strongest known common genetic risk factor; ε2 is the strongest protective allele. Risk is modified by lifestyle, sleep, and cardiovascular health. |
| Coronary artery disease | Modestly increased risk (ε4) | Mediated by elevated LDL and plaque accumulation; benefits from standard cardiovascular prevention. |
| Type-III hyperlipoproteinemia | Strongly increased risk (ε2/ε2 only) | Rare; characterized by elevated chylomicron remnants and triglycerides; specialist management. |
| Traumatic brain injury recovery | Worse outcomes (ε4) | ε4 carriers recover more slowly from TBI; relevant for athletes and veterans. |
ε4 carriers absorb saturated fat more efficiently and are more sensitive to its LDL-raising effect. The Mediterranean and MIND diets are the only patterns with RCT evidence for cognitive benefit, with the strongest signal in ε4 carriers.
| Supplement | Typical dose | Form | Notes |
|---|---|---|---|
| Omega-3 (DHA-dominant) | 1-2 g DHA/day | Triglyceride-form fish oil or algae oil | Strongest evidence in ε4 carriers BEFORE cognitive symptoms appear; less benefit after onset. |
| Vitamin D3 | 2000-4000 IU/day to reach 25(OH)D 40-60 ng/mL | D3 with K2 (MK-7) | Low D linked to faster cognitive decline. |
| Curcumin (with piperine or phytosomal) | 500-1000 mg/day | Meriva or BCM-95 | Crosses blood-brain barrier; modest evidence for cognition. |
| Citicoline (CDP-choline) | 250-500 mg/day | Standard | Supports membrane phospholipids; some evidence in mild cognitive impairment. |
No. ε4 raises lifetime risk but is neither necessary nor sufficient. About 40-65% of people with Alzheimer's carry at least one ε4, but many ε4 carriers — even ε4/ε4 — never develop the disease, and many non-carriers do.
Mediterranean and MIND diets have the strongest evidence: olive oil, fatty fish, leafy greens, berries, nuts, beans, with low saturated fat and refined carbs. Avoid coconut oil and MCT oil — they raise LDL in ε4 carriers without proven cognitive benefit.
Likely yes, if started in midlife before symptoms — 1-2 g/day of DHA-dominant omega-3. The evidence weakens once cognitive impairment is established.
Decision should be individualized with a cardiologist based on ApoB, Lp(a), 10-year risk, and family history — not on APOE genotype alone. ε4 itself does not change statin response meaningfully.
ε2 lowers Alzheimer risk but ε2/ε2 carriers can develop type-III hyperlipoproteinemia (high triglycerides + cholesterol). One ε2 (ε2/ε3) is generally favorable.
Knowing your APOE genotype is informative but emotionally significant and not always clinically actionable. Consider genetic counseling first. The lifestyle interventions that benefit ε4 carriers benefit everyone.
This page is informational and does not constitute medical advice, diagnosis or treatment. Genetic risk is one input among many — diet, exercise, sleep, environment and family history all matter. Consult a qualified healthcare professional before starting or stopping any supplement, medication or treatment.